APA (7th ed.) Citation

Liao, P., Wang, P., & Peng, T. (2023). Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Current Oncology, 30(11), 9940. https://doi.org/10.3390/curroncol30110722

Chicago Style (17th ed.) Citation

Liao, Pei-Fei, Ping-Yu Wang, and Tzu-Rong Peng. "Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis." Current Oncology 30, no. 11 (2023): 9940. https://doi.org/10.3390/curroncol30110722.

MLA (9th ed.) Citation

Liao, Pei-Fei, et al. "Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis." Current Oncology, vol. 30, no. 11, 2023, p. 9940, https://doi.org/10.3390/curroncol30110722.